Evidence map›Paper›PMID 25620120›Full record

ArticleSchizophrenia research2015

Abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis.

Patricia Alvarado-Alanis, Pablo León-Ortiz, Francisco Reyes-Madrigal, Rafael Favila, Oscar Rodríguez-Mayoral, Humberto Nicolini, Mariana Azcárraga, Ariel Graff-Guerrero, Laura M Rowland, Camilo de la Fuente-Sandoval

Erratum issuedAbstract read
In one paragraph

Article in Schizophrenia research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Patricia Alvarado-AlanisLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Pablo León-OrtizLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico; Department of Education, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Francisco Reyes-MadrigalLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Rafael FavilaMR Advanced Applications, GE Healthcare, Mexico City, Mexico.
Oscar Rodríguez-MayoralEarly Psychosis Intervention Department, Hospital Fray Bernardino Álvarez, Mexico City, Mexico; Palliative Care Unit, Instituto Nacional de Cancerología, Mexico City, Mexico.
Humberto NicoliniInstituto Nacional de Medicina Genómica, Mexico City, Mexico.
Mariana AzcárragaNeuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Ariel Graff-GuerreroMultimodal Neuroimaging Schizophrenia Group, Research Imaging Centre and Geriatric Mental Health Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Canada.
Laura M RowlandMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, USA; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, USA.
Camilo de la Fuente-SandovalLaboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico; Neuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. Electronic address: fcamilo@unam.mx.

Funding

Multimodal neuroimaging study of relational learning in schizophreniaR01MH094520 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI ROWLAND, LAURA M · 2012 to 2016
$1.9M
Canadian Institutes of Health Research MOP-114989NIMH NIH HHS R01 MH094520
6 · The paper itself

Abstract

introductionDiffusion tensor imaging (DTI) studies in patients with schizophrenia have shown abnormalities in the microstructure of white matter tracts. Specifically, reduced fractional anisotropy (FA) has been described across multiple white matter tracts, in studies that have mainly included patients treated with antipsychotic medications.

objectiveTo compare FA in antipsychotic-naïve patients experiencing a first episode of psychosis (FEP) to FA in healthy controls to demonstrate that the variance of FA can be grouped, in a coincidental manner, in four predetermined factors in accordance with a theoretical partition of the white matter tracts, using a principal components analysis (PCA).

methodsThirty-five antipsychotic-naïve FEP patients and 35 age- and gender-matched healthy controls underwent DTI at 3T. Analysis was performed using a tract-based spatial statistics (TBSS) method and exploratory PCA.

resultsDTI analysis showed extensive FA reduction in white matter tracts in FEP patients compared with the control group. The PCA grouped the white matter tracts into four factors explaining 66% of the total variance. Comparison of the FA values within each factor highlighted the differences between FEP patients and controls. DISCUSSION: Our study confirms extensive white matter tracts anomalies in patients with schizophrenia, more specifically, in drug-naïve FEP patients. The results also indicate that a small number of white matter tracts share common FA anomalies that relate to deficit symptoms in FEP patients. Our study adds to a growing body of literature emphasizing the need for treatments targeting white matter function and structure in FEP patients.

Indexed as

AnisotropyBrainDiffusion Tensor ImagingFemaleHumansMagnetic Resonance ImagingMalePrincipal Component AnalysisSchizophreniaWhite MatterYoung AdultDiffusion tensor imagingFirst-episode psychosisFractional anisotropyPrincipal component analysisSchizophreniaTBSS

Identifiers

PMID25620120
PMCPMC4339463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.